OPTUS Pharmaceutical Statistics

Total Valuation

OPTUS Pharmaceutical has a market cap or net worth of KRW 90.94 billion. The enterprise value is 33.03 billion.

Market Cap	90.94B
Enterprise Value	33.03B

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

OPTUS Pharmaceutical has 16.15 million shares outstanding. The number of shares has increased by 0.16% in one year.

Current Share Class	n/a
Shares Outstanding	16.15M
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	5.71%
Float	9.52M

Valuation Ratios

The trailing PE ratio is 9.04.

PE Ratio	9.04
Forward PE	n/a
PS Ratio	1.09
PB Ratio	0.62
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.91, with an EV/FCF ratio of -245.73.

EV / Earnings	3.47
EV / Sales	0.42
EV / EBITDA	2.91
EV / EBIT	4.47
EV / FCF	-245.73

Financial Position

The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.01.

Current Ratio	6.62
Quick Ratio	5.47
Debt / Equity	0.01
Debt / EBITDA	0.14
Debt / FCF	-12.25
Interest Coverage	70.56

Financial Efficiency

Return on equity (ROE) is 7.03% and return on invested capital (ROIC) is 3.37%.

Return on Equity (ROE)	7.03%
Return on Assets (ROA)	3.09%
Return on Capital (ROIC)	3.37%
Revenue Per Employee	495.62M
Profits Per Employee	59.83M
Employee Count	159
Asset Turnover	0.53
Inventory Turnover	2.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+11.05%
50-Day Moving Average	5,914.30
200-Day Moving Average	6,524.73
Relative Strength Index (RSI)	50.58
Average Volume (20 Days)	56,816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OPTUS Pharmaceutical had revenue of KRW 78.80 billion and earned 9.51 billion in profits. Earnings per share was 623.09.

Revenue	78.80B
Gross Profit	43.10B
Operating Income	7.39B
Pretax Income	11.35B
Net Income	9.51B
EBITDA	11.37B
EBIT	7.39B
Earnings Per Share (EPS)	623.09

Full Income Statement

Balance Sheet

The company has 59.55 billion in cash and 1.65 billion in debt, giving a net cash position of 57.91 billion or 3,584.90 per share.

Cash & Cash Equivalents	59.55B
Total Debt	1.65B
Net Cash	57.91B
Net Cash Per Share	3,584.90
Equity (Book Value)	139.48B
Book Value Per Share	9,131.90
Working Capital	71.75B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.15 billion and capital expenditures -11.28 billion, giving a free cash flow of -134.44 million.

Operating Cash Flow	11.15B
Capital Expenditures	-11.28B
Free Cash Flow	-134.44M
FCF Per Share	-8.32

Full Cash Flow Statement

Margins

Gross margin is 54.69%, with operating and profit margins of 9.38% and 12.07%.

Gross Margin	54.69%
Operating Margin	9.38%
Pretax Margin	14.40%
Profit Margin	12.07%
EBITDA Margin	14.42%
EBIT Margin	9.38%
FCF Margin	n/a

Dividends & Yields

OPTUS Pharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	16.04%
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	11.07%
FCF Yield	-0.15%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OPTUS Pharmaceutical has an Altman Z-Score of 6.17.

Altman Z-Score	6.17
Piotroski F-Score	n/a